PODD · 10-Q · 2026Q3 · Full report

Omnipod Quality Corrections

INSULET CORP · 2026-11-04 · Importance 46 · Surprise 42 · No source text

Insulet issued two voluntary medical device corrections in March and May 2026 for separate manufacturing issues that caused cannula tears in certain Omnipod products. The company recorded a $38.5 million net charge for the corrections during the first nine months of 2026 and accrued an estimated $37.0 million liability. Warranty liability estimates were reduced by $10.7 million for the nine-month period, including a $7.0 million reduction in the third quarter, because fewer Pods required replacement than initially estimated. Total correction costs are estimated at approximately $50 million, with most expected to be incurred during 2026.

Key facts

• Insulet estimates total costs associated with the medical device corrections will be approximately $50 million, most of which it expects to incur in 2026. source
• Insulet recorded a net charge of $38.5 million associated with the medical device corrections during the nine months ended September 30, 2026. source
• Insulet issued two voluntary medical device corrections in March and May 2026 related to separate manufacturing issues that caused a tear in the cannula of certain Omnipod products. source

Impact estimates